epirubicin has been researched along with Bacterial Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duarte, MP; Galhano, J; Marcelo, GA; Oliveira, E | 1 |
| Bertini, M; Botto, B; Cinieri, S; Ciotti, R; Di Nota, A; Di Vito, F; Freilone, R; Levis, A; Orsucci, L; Pini, M; Resegotti, L; Rota-Scalabrini, D; Todeschini, G; Vitolo, U | 1 |
1 trial(s) available for epirubicin and Bacterial Disease
| Article | Year |
|---|---|
The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bleomycin; Bone Marrow; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ketoconazole; Lymphoma, Non-Hodgkin; Male; Mycoses; Neoplasm Staging; Ofloxacin; Prednisone; Prognosis; Prospective Studies; Recombinant Proteins; Survival Rate; Vinblastine | 1996 |
1 other study(ies) available for epirubicin and Bacterial Disease
| Article | Year |
|---|---|
Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica-based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bacterial Infections; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Delivery Systems; Enterococcus faecalis; Epirubicin; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Nanoparticles; Ofloxacin; Particle Size; Porosity; Pseudomonas aeruginosa; Silicon Dioxide; Staphylococcus aureus; Structure-Activity Relationship; Surface Properties | 2022 |